Literature DB >> 25727151

Functional impact of tumor-specific N-linked glycan changes in breast and ovarian cancers.

Huabei Guo1, Karen L Abbott2.   

Abstract

Changes in glycosylation have been implicated in various human diseases, including cancer. Research over the past few decades has produced significant findings that illustrate the importance of cancer-specific alterations in glycosylation in the regulation of tumor formation and metastasis. The identification of glycan-based biomarkers and strategies targeting specific glycan epitopes on the tumor cell surface has become one of the widely pursued research areas. In this chapter, we will summarize and provide perspective on available knowledge about the functional roles that glycan structures play in the development and progression of the gynecological cancers, breast and ovarian, with a specific focus on N-linked glycans. A better understanding of the functional roles for glycans in cancer will drive future innovations for diagnostics and therapeutics.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast; Cancer; Functional impact; Glycan; N-linked; Ovarian; Tumor

Mesh:

Substances:

Year:  2015        PMID: 25727151     DOI: 10.1016/bs.acr.2014.11.006

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  13 in total

Review 1.  Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition.

Authors:  Reem Malek; Hailun Wang; Kekoa Taparra; Phuoc T Tran
Journal:  Cells Tissues Organs       Date:  2017-02-20       Impact factor: 2.481

2.  Automating a Process Convolution Approach to Account for Spatial Information in Imaging Mass Spectrometry Data.

Authors:  Cameron Miller; Andrew Lawson; Dongjun Chung; Mulugeta Gebregziabher; Elizabeth Yeh; Richard Drake; Elizabeth Hill
Journal:  Spat Stat       Date:  2020-02-19

Review 3.  Glycans and glycoproteins as specific biomarkers for cancer.

Authors:  Muchena J Kailemia; Dayoung Park; Carlito B Lebrilla
Journal:  Anal Bioanal Chem       Date:  2016-09-03       Impact factor: 4.142

4.  N-Glycan Profile of Cerebrospinal Fluids from Alzheimer's Disease Patients Using Liquid Chromatography with Mass Spectrometry.

Authors:  Byeong Gwan Cho; Lucas Veillon; Yehia Mechref
Journal:  J Proteome Res       Date:  2019-09-16       Impact factor: 4.466

Review 5.  Applications and continued evolution of glycan imaging mass spectrometry.

Authors:  Colin T McDowell; Xiaowei Lu; Anand S Mehta; Peggi M Angel; Richard R Drake
Journal:  Mass Spectrom Rev       Date:  2021-08-15       Impact factor: 10.946

6.  Characterization of glycan isomers using magnetic carbon nanoparticles as a MALDI co-matrix.

Authors:  Alireza Banazadeh; Reed Nieman; Mona Goli; Wenjing Peng; Ahmed Hussein; Ercan Bursal; Hans Lischka; Yehia Mechref
Journal:  RSC Adv       Date:  2019-06-27       Impact factor: 4.036

7.  Increases in Tumor N-Glycan Polylactosamines Associated with Advanced HER2-Positive and Triple-Negative Breast Cancer Tissues.

Authors:  Danielle A Scott; Rita Casadonte; Barbara Cardinali; Laura Spruill; Anand S Mehta; Franca Carli; Nicole Simone; Mark Kriegsmann; Lucia Del Mastro; Joerg Kriegsmann; Richard R Drake
Journal:  Proteomics Clin Appl       Date:  2019-01       Impact factor: 3.494

Review 8.  MS-based glycomics and glycoproteomics methods enabling isomeric characterization.

Authors:  Wenjing Peng; Cristian D Gutierrez Reyes; Sakshi Gautam; Aiying Yu; Byeong Gwan Cho; Mona Goli; Kaitlyn Donohoo; Stefania Mondello; Firas Kobeissy; Yehia Mechref
Journal:  Mass Spectrom Rev       Date:  2021-06-22       Impact factor: 9.011

Review 9.  Hijacking the Hexosamine Biosynthetic Pathway to Promote EMT-Mediated Neoplastic Phenotypes.

Authors:  Kekoa Taparra; Phuoc T Tran; Natasha E Zachara
Journal:  Front Oncol       Date:  2016-04-18       Impact factor: 6.244

10.  Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma.

Authors:  Merrina Anugraham; Francis Jacob; Arun V Everest-Dass; Andreas Schoetzau; Sheri Nixdorf; Neville F Hacker; Daniel Fink; Viola Heinzelmann-Schwarz; Nicolle H Packer
Journal:  Mol Oncol       Date:  2017-09-29       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.